Area of research
Pulmonary and Respiratory Medicine · Biotechnology
Research interest
Research interests include Occupational and environmental lung diseases, Cancer Research and Treatments, Medical Imaging and Pathology Studies, and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations
Germline <i>BARD1</i> variants predispose to mesothelioma by impairing DNA repair and calcium signaling
Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?
HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma
BAP1 is a novel regulator of HIF-1α
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy
BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos
Biological Mechanisms and Clinical Significance of <i>BAP1</i> Mutations in Human Cancer
Tumour predisposition and cancer syndromes as models to study gene–environment interactions
Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy
Heterozygous germline <i>BLM</i> mutations increase susceptibility to asbestos and mesothelioma
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation
Scientific Advances and New Frontiers in Mesothelioma Therapeutics
Progress in the Management of Malignant Pleural Mesothelioma in 2017
Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine
Abstract 5519: BAP1 modulates gene-environment interaction in carcinogenesis
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
Germline BAP1 mutations induce a Warburg effect
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
Consensus guidelines for the detection of immunogenic cell death
Evaluation of clonal origin of malignant mesothelioma
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma